X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Before LINN, FRIEDMAN, and DYK, Circuit Judges.

Abbott Diabetes Care, Inc. and Abbott Laboratories (collectively “Abbott”) appeal the final decision of the U.S. District Court for the Northern District of California, which entered judgment in accordance with a jury verdict that claims 11 and 12 of Abbott’s U.S. Patent No. 5,628,890 (“the ’890 patent”) are infringed by Becton, Dickinson & Co. and Nova Biomedical Corp. (collectively “BD/Nova”) but are invalid under 35 U.S.C. §§ 102, 103, and 112 ¶ 1, and denied Abbott’s post-trial motions for judgment as a matter of law (“JMOL”) and for new trial. Therasense, Inc. v. Becton, Dickinson & Co., No. 04-CV-2123 (N.D. Cal. Sept. 2, 2008). Although judgment was entered in favor of BD/Nova on all counts relating to the ’890 patent, BD/Nova cross-appeals the jury’s underlying finding that it infringes claims 11 and 12. Because we conclude that the district court did not err in denying Abbott’s post-trial motions on invalidity, and because we lack jurisdiction over BD/Nova’s cross-appeal, we dismiss the cross-appeal and affirm the judgment.

BACKGROUND

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

More From ALM

With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now
September 18, 2024 - September 19, 2024
Dallas, TX

Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies


Learn More
October 22, 2024 - October 23, 2024
New York, NY

Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies


Learn More
November 13, 2024
New York, NY

Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.


Learn More

Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...


Apply Now ›

Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...


Apply Now ›

Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...


Apply Now ›
04/15/2024
Connecticut Law Tribune

MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS


View Announcement ›
04/11/2024
New Jersey Law Journal

Professional Announcement


View Announcement ›
04/08/2024
Daily Report

Daily Report 1/2 Page Professional Announcement 60 Days


View Announcement ›

The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.

American Lawyer